Differences in the Food Consumption Between Kidney Stone Formers and Nonformers in the Swiss Kidney Stone Cohort.


Journal

Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation
ISSN: 1532-8503
Titre abrégé: J Ren Nutr
Pays: United States
ID NLM: 9112938

Informations de publication

Date de publication:
07 2023
Historique:
received: 19 06 2022
revised: 09 04 2023
accepted: 16 04 2023
medline: 4 7 2023
pubmed: 30 4 2023
entrez: 29 4 2023
Statut: ppublish

Résumé

Diet has a major influence on the formation and management of kidney stones. However, kidney stone formers' diet is difficult to capture in a large population. Our objective was to describe the dietary intake of kidney stone formers in Switzerland and to compare it to nonstone formers. We used data from the Swiss Kidney Stone Cohort (n = 261), a multicentric cohort of recurrent or incident kidney stone formers with additional risk factors, and a control group of computed tomography-scan proven nonstone formers (n = 197). Dieticians conducted two consecutive 24-h dietary recalls, using structured interviews and validated software (GloboDiet). We took the mean consumption per participant of the two 24-h dietary recalls to describe the dietary intake and used two-part models to compare the two groups. The dietary intake was overall similar between stone and nonstone formers. However, we identified that kidney stone formers had a higher probability of consuming cakes and biscuits (odds ratio (OR) [95% CI] = 1.56[1.03; 2.37]) and soft drinks (OR = 1.66[1.08; 2.55]). Kidney stone formers had a lower probability of consuming nuts and seeds (OR = 0.53[0.35; 0.82]), fresh cheese (OR = 0.54[0.30; 0.96]), teas (OR = 0.50[0.3; 0.84]), and alcoholic beverages (OR = 0.35[0.23; 0.54]), especially wine (OR = 0.42[0.27; 0.65]). Furthermore, among consumers, stone formers reported smaller quantities of vegetables (β coeff[95% CI] = - 0.23[- 0.41; - 0.06]), coffee (β coeff = - 0.21[- 0.37; - 0.05]), teas (β coeff = - 0.52[- 0.92; - 0.11]) and alcoholic beverages (β coeff = - 0.34[- 0.63; - 0.06]). Stone formers reported lower intakes of vegetables, tea, coffee, and alcoholic beverages, more specifically wine, but reported drinking more frequently soft drinks than nonstone formers. For the other food groups, stone formers and nonformers reported similar dietary intakes. Further research is needed to better understand the links between diet and kidney stone formation and develop dietary recommendations adapted to the local settings and cultural habits.

Identifiants

pubmed: 37120128
pii: S1051-2276(23)00067-5
doi: 10.1053/j.jrn.2023.04.007
pii:
doi:

Substances chimiques

Coffee 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-565

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Constance Legay (C)

Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; Center for Primary Care and Public Health (Unisanté), Department of Epidemiology and Health Systems, University of Lausanne, Lausanne, Switzerland; National Center of Competence in Research NCCR Kidney.CH, Switzerland.

Tanja Haeusermann (T)

National Center of Competence in Research NCCR Kidney.CH, Switzerland.

Jérôme Pasquier (J)

Center for Primary Care and Public Health (Unisanté), Department Formation, Research and Innovation, University of Lausanne, Lausanne, Switzerland.

Angeline Chatelan (A)

Department of Nutrition and Dietetics, Geneva School of Health Sciences, HES-SO University of Applied Sciences and Arts Western, Geneva, Switzerland; Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Daniel G Fuster (DG)

National Center of Competence in Research NCCR Kidney.CH, Switzerland; Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Nasser Dhayat (N)

Department of Nephrology and Hypertension, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Harald Seeger (H)

Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.

Alexander Ritter (A)

Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.

Nilufar Mohebbi (N)

Division of Nephrology, University Hospital Zurich, Zurich, Switzerland.

Thomas Ernandez (T)

Service of Nephrology, Geneva University Hospitals, Geneva, Switzerland.

Catherine Stoermann Chopard (CS)

Service of Nephrology, Geneva University Hospitals, Geneva, Switzerland.

Florian Buchkremer (F)

Division of Nephrologie, Dialyse und Transplantation, Kantonsspital Aarau, Aarau, Switzerland.

Stephan Segerer (S)

Division of Nephrologie, Dialyse und Transplantation, Kantonsspital Aarau, Aarau, Switzerland.

Grégoire Wuerzner (G)

Service of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland.

Nadia Ammor (N)

Service of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland.

Beat Roth (B)

Department of Urology, Lausanne University Hospital, CHUV, University of Lausanne, Switzerland.

Carsten A Wagner (CA)

National Center of Competence in Research NCCR Kidney.CH, Switzerland; Institute of Physiology, University of Zurich, Zurich, Switzerland.

Olivier Bonny (O)

Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland; National Center of Competence in Research NCCR Kidney.CH, Switzerland; Service of Nephrology and Hypertension, Lausanne University Hospital, Lausanne, Switzerland; Service of Nephrology, Fribourg State Hospital, Fribourg, Switzerland. Electronic address: Olivier.Bonny@h-fr.ch.

Murielle Bochud (M)

Center for Primary Care and Public Health (Unisanté), Department of Epidemiology and Health Systems, University of Lausanne, Lausanne, Switzerland; National Center of Competence in Research NCCR Kidney.CH, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH